Qing Zhu, Ph.D.
Vice President, Head of Biopharmaceutical Research
Prior to joining the company, Dr. Zhu spent 10 years at MedImmune in the United States, where she served as the Director of Infectious Diseases and Vaccines with a particular focus in the fields of antiviral biologics and novel biotherapeutics. At MedImmune, Dr. Zhu led cross-functional matrix teams to progress antibody candidates from preclinical to clinical studies, and contributed to regulatory submissions (IND/BLA) of several antibody drugs targeting respiratory syncytia virus and influenza.
Earlier in her career, Dr. Zhu held positions of increasing responsibility at Chiron Corporation (later Novartis Vaccines and Diagnostics) developing vaccines and a small molecular inhibitor against the hepatitis C virus. Dr. Zhu received her Ph.D. in molecular and cell biology from the University of Maryland. She completed her post-doctoral training in the virology program at Fox Chase Cancer Center.